121 related articles for article (PubMed ID: 11701227)
1. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells.
Siegel D; Ryder J; Ross D
Toxicol Lett; 2001 Dec; 125(1-3):93-8. PubMed ID: 11701227
[TBL] [Abstract][Full Text] [Related]
2. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.
Moran JL; Siegel D; Ross D
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8150-5. PubMed ID: 10393963
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion.
Zhou H; Dehn D; Kepa JK; Siegel D; Scott DE; Tan W; Ross D
J Pharmacol Exp Ther; 2010 Jul; 334(1):260-8. PubMed ID: 20378716
[TBL] [Abstract][Full Text] [Related]
4. Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function.
Ross D; Zhou H; Siegel D
Chem Biol Interact; 2011 Jun; 192(1-2):145-9. PubMed ID: 20970411
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
Siegel D; McGuinness SM; Winski SL; Ross D
Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
Siegel D; Kepa JK; Ross D
PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.
Long DJ; Gaikwad A; Multani A; Pathak S; Montgomery CA; Gonzalez FJ; Jaiswal AK
Cancer Res; 2002 Jun; 62(11):3030-6. PubMed ID: 12036909
[TBL] [Abstract][Full Text] [Related]
8. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
Dehn DL; Winski SL; Ross D
Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
[TBL] [Abstract][Full Text] [Related]
9. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity.
Ross D
Chem Biol Interact; 2005 May; 153-154():137-46. PubMed ID: 15935810
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG
Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity.
Ross D; Siegel D; Schattenberg DG; Sun XM; Moran JL
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1177-82. PubMed ID: 9118890
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues.
Siegel D; Ross D
Free Radic Biol Med; 2000 Aug; 29(3-4):246-53. PubMed ID: 11035253
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D
Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
[TBL] [Abstract][Full Text] [Related]
14. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Siegel D; Franklin WA; Ross D
Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
[TBL] [Abstract][Full Text] [Related]
17. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
[TBL] [Abstract][Full Text] [Related]
18. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines.
Bruge F; Virgili S; Cacciamani T; Principi F; Tiano L; Littarru GP
Biofactors; 2008; 32(1-4):71-81. PubMed ID: 19096102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]